You are here: Industry Insights > chemotherapy

News List

FDA Approves Atezolizumab with Chemotherapy and Bevacizumab for First-Line Treatment of Metastatic Non-Squamous NSCLC americanpharmaceuticalreview
December 10, 2018
On December 6, 2018, the Food and Drug Administration approved atezolizumab (TECENTRIQ, Genentech, Inc.), in combination with bevacizumab, paclitaxel, and carboplatin .....
Biosimilar Pegfilgrastim Co-Developed by Biocon Receives Approval in EU firstwordpharma
December 02, 2018
Biosimilar Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy.
Discovery of cancer ‘kill code’ could inspire new treatments fiercebiotech
November 02, 2018
Scientists at Northwestern University have discovered a “kill code” in every cell of the body that’s triggered by chemotherapy and that causes cancerous cells to self-destruct. What’s more, they’...
Latest lung cancer data could open new avenue for Roche’s Tecentriq pharmaphorum
September 27, 2018
Roche is eyeing a new use for its checkpoint inhibitor immunotherapy Tecentriq after it posted results showing it extended patients’ lives...
Research backs halving chemo after bowel cancer surgery pharmatimes
July 19, 2018
Some patients receiving chemotherapy after surgery for bowel cancer might only need three months of treatment rather than the six months currently given, according to new research published in the Lancet Oncology.
News of Note—A drug to reduce age-related stomach damage; a CAR-T to attack colon tumors fiercebiotech
May 08, 2018
Scientists at the Massachusetts Institute of Technology have discovered in mouse experiments that a decline in intestinal stem cells that typically occurs during aging can be reversed with 24 hours of fasting...
FDA grants Keytruda priority review pharmatimes
May 02, 2018
The FDA has accepted for review Merck & Co's anti-PD-1 therapy Keytruda in combination with Eli Lilly's Alimta (pemetrexed) and platinum chemotherapy ...
Cells of 3 advanced cancers die with drug-like compounds that reverse chemo failure worldpharmanews
January 24, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers - ovarian, prostate and breast.
Nanoshells could deliver more chemo with fewer side effects europeanpharmaceuticalreview
November 10, 2017
In vitro study verifies method for remotely triggering release of cancer drugs…
New study suggests jet lag drug benefits patients undergoing chemotherapy pharmaceufical-technology
September 21, 2017
A recent study conducted by scientists at the Universities of Edinburgh and Aberdeen has suggested that painful side effects from cancer medicines can be managed using melatonin, a drug that helps ease the effects of jet lag.

Previous page 1 2 3 4 5 Next page